 epstein-barr virus-rel antibodi chang titer therapi nasopharyng carcinoma long-term follow-up data prospect collabor studi north american patient signific variou serolog test antibodi epstein-barr viru outcom treatment patient nasopharyng carcinoma patient repeat measur titer variou time diagnosi treatment associ trend titer slope log titer time level mean log titer outcom aliv evid diseas aliv recurr nasopharyng carcinoma posttreat sequenti measur outcom